Your session is about to expire
← Back to Search
Paclitaxel for Breast Cancer
Study Summary
This trial is testing whether lengthening the infusion time for paclitaxel normalizes levels of the drug in patients with low muscle mass.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 4 trial • 32 Patients • NCT01301729Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are able to understand the nature and purpose of the study and are willing to sign a written informed consent.My breast cancer is at stage 1, 2, or 3.My organs are working well enough for chemotherapy.My organs are healthy enough for chemotherapy.My breast cancer is at stage 1, 2, or 3.I am scheduled for a specific chemotherapy treatment plan.Evaluable computed tomography (CT) scan, e.g.I am not taking medications like rifampin or clopidogrel that strongly affect liver enzymes.I am scheduled for treatment with paclitaxel and possibly other drugs for my cancer.
- Group 1: Normal SMA (>7310 mm^2)
- Group 2: Low SMA (5120 - 7310 mm^2) and Sarcopenic SMA (<5120 mm^2)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the regulatory agency sanctioned Paclitaxel?
"Paclitaxel has been approved, so it scored a 3 on our safety scale."
What is the current enrollment size of this research trial?
"Affirmative. Information posted on clinicaltrials.gov declares that recruitment for this medical trial is still ongoing, having first been announced on March 28th 2022 and updated most recently on July 18th 2022. This study requires the enrolment of 22 volunteers from a single site."
Is there any availability for participation in this research initiative?
"According to data found on clinicaltrials.gov, this trial is currently seeking volunteers. The initial listing was posted on March 28th 2022 and the details were recently updated on July 18th of the same year."
Share this study with friends
Copy Link
Messenger